DK1815028T3 - Mikrobobler til affinitetsseparation - Google Patents

Mikrobobler til affinitetsseparation

Info

Publication number
DK1815028T3
DK1815028T3 DK05858304.8T DK05858304T DK1815028T3 DK 1815028 T3 DK1815028 T3 DK 1815028T3 DK 05858304 T DK05858304 T DK 05858304T DK 1815028 T3 DK1815028 T3 DK 1815028T3
Authority
DK
Denmark
Prior art keywords
microbubbles
affinity
affinity separation
methods
coated
Prior art date
Application number
DK05858304.8T
Other languages
Danish (da)
English (en)
Inventor
Thomas Adams
Edward Jablonski
Original Assignee
Iris Molecular Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iris Molecular Diagnostics Inc filed Critical Iris Molecular Diagnostics Inc
Application granted granted Critical
Publication of DK1815028T3 publication Critical patent/DK1815028T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/545—Synthetic resin
    • G01N33/546—Synthetic resin as water suspendable particles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/545—Synthetic resin
    • G01N33/547—Synthetic resin with antigen or antibody attached to the carrier via a bridging agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/552—Glass or silica
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/76—Assays involving albumins other than in routine use for blocking surfaces or for anchoring haptens during immunisation
    • G01N2333/765—Serum albumin, e.g. HSA
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Inorganic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK05858304.8T 2004-11-03 2005-11-03 Mikrobobler til affinitetsseparation DK1815028T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62494804P 2004-11-03 2004-11-03
PCT/US2005/040162 WO2006137933A2 (en) 2004-11-03 2005-11-03 Microbubbles for affinity separation

Publications (1)

Publication Number Publication Date
DK1815028T3 true DK1815028T3 (da) 2012-01-30

Family

ID=37570908

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05858304.8T DK1815028T3 (da) 2004-11-03 2005-11-03 Mikrobobler til affinitetsseparation

Country Status (12)

Country Link
US (3) US8835186B2 (https=)
EP (2) EP2302078B1 (https=)
JP (2) JP5037350B2 (https=)
KR (1) KR101281433B1 (https=)
CN (2) CN103091485A (https=)
AT (1) ATE530666T1 (https=)
AU (1) AU2005333157B2 (https=)
CA (1) CA2585675A1 (https=)
DK (1) DK1815028T3 (https=)
ES (2) ES2376578T3 (https=)
PT (1) PT1815028E (https=)
WO (1) WO2006137933A2 (https=)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103091485A (zh) 2004-11-03 2013-05-08 艾瑞斯国际有限公司 用于亲和分离的微泡
DE602005023529D1 (de) 2004-11-03 2010-10-21 Iris Molecular Diagnostics Inc Homogener nachweis von analyten
WO2012161226A1 (ja) * 2011-05-23 2012-11-29 積水メディカル株式会社 Pivka-ii測定試薬における非特異反応の抑制方法
WO2013096157A1 (en) * 2011-12-21 2013-06-27 3M Innovative Properties Company Bioseparation compositions and methods for making and using same
KR101462986B1 (ko) 2012-06-25 2014-11-19 대한민국 분변 중 요네균 신속분리를 위한 자석 나노입자를 이용한 검출방법
US20140288421A1 (en) * 2013-03-12 2014-09-25 The Regents Of The University Of California Gas vesicle ultrasound contrast agents and methods of using the same
EP3933384A1 (en) 2013-03-15 2022-01-05 Hycor Biomedical, LLC Device and associated method for performing luminescence and fluorescence measurements of a sample
WO2015198153A2 (en) * 2014-01-28 2015-12-30 Targeson, Inc. Isolation of cells and biological substances using buoyant microbubbles
JP6557681B2 (ja) * 2014-05-10 2019-08-07 ダイアグノロジックス・エルエルシー 浮力を用いて薬剤を単離または濃縮するためのシステムおよび装置
US11291931B2 (en) * 2014-12-15 2022-04-05 Akadeum Life Sciences, Inc. Method and system for buoyant separation
WO2016100290A1 (en) 2014-12-15 2016-06-23 Akadeum Life Sciences, LLC Method and system for buoyant separation
JP6716683B2 (ja) 2015-05-01 2020-07-01 バイオレジェンド，インコーポレイテッド 安定なナノ磁性粒子分散
CN108780081B (zh) 2015-08-10 2021-04-09 Essenlix公司 步骤简化、小样品、快速、易使用的生物/化学分析装置和方法
HK1250543A1 (zh) 2015-08-24 2018-12-21 日本瑞翁株式会社 用於多步骤细胞纯化和浓缩的方法和装置
US10976232B2 (en) 2015-08-24 2021-04-13 Gpb Scientific, Inc. Methods and devices for multi-step cell purification and concentration
WO2017048871A1 (en) 2015-09-14 2017-03-23 Essenlix Corp. Device and system for analyzing a sample, particularly blood, as well as methods of using the same
CN111426822B (zh) 2015-09-14 2022-12-13 艾森利克斯公司 采集分析蒸汽凝析，特别是呼出气凝析的装置与系统，以及使用方法
EP3892316A3 (en) * 2015-12-29 2021-11-24 Thermogenesis Corp. Cell separation devices, systems, and methods
WO2017190117A1 (en) * 2016-04-30 2017-11-02 BioLegend, Inc. Compositions and methods for performing magnetibuoyant separations
KR102381114B1 (ko) * 2016-10-06 2022-03-30 아이리스 인터내셔널 인크. 동적 포커스 시스템 및 방법들
WO2018112262A2 (en) 2016-12-16 2018-06-21 Diagnologix, Llc Buoyancy enabled separation method and system
US10628693B2 (en) 2016-12-21 2020-04-21 Essenlix Corporation Devices and methods for authenticating a sample and use of the same
WO2018148342A1 (en) 2017-02-07 2018-08-16 Essenlix Corporation Compressed open flow assay and use
US11927560B2 (en) 2017-02-08 2024-03-12 Essenlix Corporation Bio/chemical material extraction and assay
CA3052809A1 (en) 2017-02-08 2018-08-23 Essenlix Corporation Qmax assays and applications
CN111656155B (zh) 2017-02-08 2024-05-31 上海宜晟生物科技有限公司 用于延迟分析的样品采集和操作
CN110998324B (zh) 2017-02-08 2025-03-28 上海宜晟生物科技有限公司 数字测定
US12151246B2 (en) 2017-02-08 2024-11-26 Essenlix Corporation Molecular manipulation and assay with controlled temperature
CN111433606B (zh) 2017-02-09 2024-05-24 上海宜晟生物科技有限公司 采用不同间距高度的测定
CN110998325B (zh) 2017-02-09 2024-08-16 上海宜晟生物科技有限公司 扩增测定
EP3662259A4 (en) 2017-02-09 2021-08-25 Essenlix Corporation COLORIMETRIC TESTS
JP2020508043A (ja) 2017-02-15 2020-03-19 エッセンリックス コーポレーション 急速な温度変化を伴うアッセイ
US11523752B2 (en) 2017-02-16 2022-12-13 Essenlix Corporation Assay for vapor condensates
EP3638421A4 (en) 2017-06-12 2021-04-07 Essenlix Corporation HOMOGENOUS ASSAY
CN120668916A (zh) 2017-08-01 2025-09-19 上海宜晟生物科技有限公司 检查药物对微生物影响的装置和方法
WO2019028123A1 (en) 2017-08-01 2019-02-07 Essenlix Corporation COLLECTION, MAINTENANCE AND DETERMINATION OF SAMPLES
US11280706B2 (en) 2017-08-01 2022-03-22 Essenlix Corporation Dilution calibration
WO2019075244A1 (en) 2017-10-11 2019-04-18 Essenlix Corporation CONTAINING A LIQUID SAMPLE
WO2019075415A1 (en) 2017-10-13 2019-04-18 Essenlix Corporation DEVICES AND METHODS FOR AUTHENTICATING MEDICAL ANALYSIS AND USES THEREOF
US11237113B2 (en) 2017-10-26 2022-02-01 Essenlix Corporation Rapid pH measurement
US10807095B2 (en) 2017-10-26 2020-10-20 Essenlix Corporation Making and tracking assay card
US11609224B2 (en) 2017-10-26 2023-03-21 Essenlix Corporation Devices and methods for white blood cell analyses
US11648551B2 (en) 2017-12-12 2023-05-16 Essenlix Corporation Sample manipulation and assay with rapid temperature change
CN112534259A (zh) 2017-12-14 2021-03-19 Essenlix公司 监测毛发的装置，系统和方法
WO2019140334A1 (en) 2018-01-11 2019-07-18 Essenlix Corporation Homogeneous assay (ii)
CN111902720B (zh) 2018-03-21 2025-02-07 沃特世科技公司 基于非抗体高亲和力的样品制备、吸附剂、装置和方法
US11350909B2 (en) 2018-04-17 2022-06-07 California Institute Of Technology Cross amplitude modulation ultrasound pulse sequence
WO2020014273A1 (en) 2018-07-09 2020-01-16 Akadeum Life Sciences, Inc. System and method for buoyant particle processing
US11885952B2 (en) 2018-07-30 2024-01-30 Essenlix Corporation Optics, device, and system for assaying and imaging
CN109608679B (zh) * 2018-12-10 2021-09-21 天津工业大学 一种核孔复合体接枝聚合物仿生膜制备方法
CN110354523B (zh) * 2019-07-14 2024-02-06 河北龙亿环境工程有限公司 一种具有多微孔气泡罩的新型塔板
WO2021059195A1 (en) * 2019-09-26 2021-04-01 3M Innovative Properties Company Compositions and methods of detecting analytes
EP4392158A4 (en) 2021-08-26 2025-09-03 Akadeum Life Sciences Inc METHOD AND SYSTEM FOR FLOATING SEPARATION
US20240368579A1 (en) * 2021-09-07 2024-11-07 Triangle Biotechnology, Inc. Targeted nanodroplet and microbubble compositions and methods for enrichment, lysis, and extraction of microbial cells
US12196754B2 (en) 2022-04-01 2025-01-14 Akadeum Life Sciences, Inc. Method and system for buoyant-particle-assisted cell therapy
JP2026511329A (ja) 2023-02-14 2026-04-14 アカデューム ライフ サイエンセズ，インコーポレイテッド 部分的または完全に自動化された浮力補助分離方法およびシステム

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1582956A (en) * 1976-07-30 1981-01-21 Ici Ltd Composite magnetic particles
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
DE3100535A1 (de) 1981-01-10 1982-08-12 Dr. Karl Thomae Gmbh, 7950 Biberach "neue carbonsaeure-derivate, ihre herstellung und ihre verwendung als arzneimittel"
FR2571498B1 (fr) * 1984-10-04 1988-04-08 Immunotech Sa Procede de separation de cellules utilisant des anticorps et des billes de faible densite
US4618525A (en) * 1985-06-03 1986-10-21 Minnesota Mining And Manufacturing Company Coated glass microbubbles and article incorporating them
US4824776A (en) * 1985-07-25 1989-04-25 Molecular Biosystems, Inc. Method for increasing the sensitivity of nucleic acid hybridization assays
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4933447A (en) * 1987-09-24 1990-06-12 Ss Pharmaceutical Co., Ltd. Quinoline derivatives
US4957656A (en) 1988-09-14 1990-09-18 Molecular Biosystems, Inc. Continuous sonication method for preparing protein encapsulated microbubbles
US5766849A (en) * 1989-07-11 1998-06-16 Gen-Probe Incorporated Methods of amplifying nucleic acids using promoter-containing primer sequence
WO1993007883A1 (en) 1991-10-24 1993-04-29 Isis Pharmaceuticals, Inc. Derivatized oligonucleotides having improved uptake and other properties
SE9002480D0 (sv) * 1990-07-23 1990-07-23 Hans Lilja Assay of free and complexed prostate-specific antigen
EP0488152A3 (en) 1990-11-30 1992-11-25 Hitachi, Ltd. Method for immunoassay and apparatus therefor
EP0529070A1 (en) * 1991-02-27 1993-03-03 Amoco Corporation Methods for improving the sensitivity of hybridization assays
IE920778A1 (en) 1991-03-12 1992-09-23 Du Pont Method for specific binding assays using a releasable ligand
US5665539A (en) * 1991-07-12 1997-09-09 The Regents Of The University Of California Immuno-polymerase chain reaction system for antigen detection
US6723303B1 (en) * 1991-09-17 2004-04-20 Amersham Health, As Ultrasound contrast agents including protein stabilized microspheres of perfluoropropane, perfluorobutane or perfluoropentane
US5270184A (en) * 1991-11-19 1993-12-14 Becton, Dickinson And Company Nucleic acid target generation
US6172208B1 (en) * 1992-07-06 2001-01-09 Genzyme Corporation Oligonucleotides modified with conjugate groups
DE4232755A1 (de) 1992-09-26 1994-03-31 Schering Ag Mikropartikelpräparationen aus biologisch abbaubaren Mischpolymeren
EP0688366B1 (en) * 1993-01-15 2002-05-22 The Public Health Research Institute Of The City Of New York, Inc. Sensitive nucleic acid sandwich hybridization assays and kits
US5985548A (en) * 1993-02-04 1999-11-16 E. I. Du Pont De Nemours And Company Amplification of assay reporters by nucleic acid replication
ATE244406T1 (de) * 1993-05-10 2003-07-15 Nissui Pharm Co Ltd Verfahren zur bestimmung von mehr als einem immunologischen liganden und bestimmungsreagenz sowie satz dafuer
US5635602A (en) * 1993-08-13 1997-06-03 The Regents Of The University Of California Design and synthesis of bispecific DNA-antibody conjugates
US5599677A (en) * 1993-12-29 1997-02-04 Abbott Laboratories Immunoassays for prostate specific antigen
US5648213A (en) * 1994-08-30 1997-07-15 Beckman Instruments, Inc. Compositions and methods for use in detection of analytes
JPH08178926A (ja) * 1994-10-25 1996-07-12 Sumitomo Pharmaceut Co Ltd イムノアッセイプレートおよびその用途
BR9509673A (pt) 1994-11-15 1997-09-30 Upjohn Co Compostos e uso dos mesmos
SE504798C2 (sv) 1995-06-16 1997-04-28 Ulf Landegren Immunanalys och testkit med två reagens som kan tvärbindas om de adsorberats till analyten
DE19524133A1 (de) * 1995-07-03 1997-01-09 Bayer Ag Die Verwendung von neuen und bekannten kationischen 4,5-Dihydro-1H-1,2,3-triazoliumverbindungen als Farbstoffe, neue kationische 4,5-Dihydro-1H-1,2,3-triazoliumverbindungen und deren Herstellung
NO301198B1 (no) 1995-07-14 1997-09-22 Alcatel Kabel Norge As Kabel, fremgangsmåte og impregneringsmasse
AT403803B (de) 1996-04-19 1998-05-25 Sanochemia Ltd Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln
US6165942A (en) 1996-10-03 2000-12-26 Nissan Chemical Industries, Ltd. Heterocycle-fused pyrimidinone derivative and herbicidal composition
US6083484A (en) * 1996-10-17 2000-07-04 Molecular Biosystems, Inc. Microparticles stabilized by polynuclear chromium complexes and their use as ultrasound contrast agents
US6245318B1 (en) 1997-05-27 2001-06-12 Mallinckrodt Inc. Selectively binding ultrasound contrast agents
US6086540A (en) * 1997-10-07 2000-07-11 Molecular Biosystems, Inc. Methods of ultrasound imaging using echogenically persistent contrast agents
US6531278B1 (en) * 1998-01-14 2003-03-11 Utah State University Ligand-DNA composition for capture and detection of contaminants on a solid surface
EP1073716B1 (en) * 1998-04-28 2004-04-28 Amersham Health AS Improvements in or relating to separation processes
US8063190B2 (en) * 1998-06-02 2011-11-22 Tom Robin Caine Boyde Nucleic acid-linked conjugates and methods for making and using them
US6214566B1 (en) * 1998-11-16 2001-04-10 The Administrators Of The Tulane Educational Fund Method for detecting anti-squalene antibodies
AU2410500A (en) 1999-01-11 2000-08-01 President And Fellows Of Harvard College Isothermal amplification of dna
ATE312350T1 (de) * 1999-10-13 2005-12-15 Univ British Columbia Verfahren zur identifizierung von verbindungen, die die neuronale aktivität modulieren
CA2391534A1 (en) * 1999-11-15 2001-05-25 Drug Innovation & Design, Inc. Selective cellular targeting: multifunctional delivery vehicles
US7306904B2 (en) * 2000-02-18 2007-12-11 Olink Ab Methods and kits for proximity probing
US6511809B2 (en) * 2000-06-13 2003-01-28 E. I. Du Pont De Nemours And Company Method for the detection of an analyte by means of a nucleic acid reporter
US7439016B1 (en) 2000-06-15 2008-10-21 Digene Corporation Detection of nucleic acids by type-specific hybrid capture method
WO2002068695A2 (en) 2001-02-22 2002-09-06 Arcturus Engineering, Inc. Quantitative immunohistochemistry (qihc)
WO2002083951A1 (en) 2001-04-10 2002-10-24 Northeastern University Multiplexed ligand/protein binding assays with pna labels
EP1249500A1 (de) 2001-04-12 2002-10-16 chimera biotec GmbH Verfahren zum Nachweis einer Substanz
WO2003011824A1 (en) 2001-07-31 2003-02-13 Bristol-Myers Squibb Company Bicyclic modulators of androgen receptor function
CA2478203C (en) 2002-03-08 2011-06-14 Eidgenossische Technische Hochschule Zurich Encoded self-assembling chemical libraries (esachel)
NZ537277A (en) * 2002-07-18 2008-04-30 Crucell Holland Bv Recombinant production of mixtures of antibodies
BR0313405A (pt) 2002-08-12 2005-07-12 Takeda Pharmaceutical Compostos, métodos para preparar um composto e para prevenir e/ou tratar câncer, prodroga, medicamento, modulador do receptor de androgênio, agente para prevenir e/ou tratar hipogonadismo ou pertubação climatérica masculina, osteoporose e câncer, e, uso de um composto
EP2290100B1 (en) 2002-11-01 2014-02-19 Iris International, Inc. Kits for displacement Sandwich Immuno-PCR
WO2006012356A2 (en) * 2004-06-23 2006-02-02 Washington University Methods for determining risk of developing regular smoking behavior
AU2005286648A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
CN103091485A (zh) 2004-11-03 2013-05-08 艾瑞斯国际有限公司 用于亲和分离的微泡
DE602005023529D1 (de) * 2004-11-03 2010-10-21 Iris Molecular Diagnostics Inc Homogener nachweis von analyten
CN103884840A (zh) * 2008-02-21 2014-06-25 艾瑞斯国际有限公司 早期确定前列腺癌治疗后复发的方法

Also Published As

Publication number Publication date
JP2012197281A (ja) 2012-10-18
CN101065497B (zh) 2012-11-21
EP2302078A1 (en) 2011-03-30
ATE530666T1 (de) 2011-11-15
CA2585675A1 (en) 2006-12-28
ES2550177T3 (es) 2015-11-05
EP2302078B1 (en) 2015-07-15
EP1815028A4 (en) 2008-09-10
ES2376578T3 (es) 2012-03-15
AU2005333157B2 (en) 2011-06-30
JP5037350B2 (ja) 2012-09-26
US20110230644A1 (en) 2011-09-22
AU2005333157A1 (en) 2006-12-28
US8835186B2 (en) 2014-09-16
KR20070110484A (ko) 2007-11-19
WO2006137933A2 (en) 2006-12-28
KR101281433B1 (ko) 2013-07-02
EP1815028A2 (en) 2007-08-08
US20110236884A1 (en) 2011-09-29
US20090176201A1 (en) 2009-07-09
CN103091485A (zh) 2013-05-08
CN101065497A (zh) 2007-10-31
US8513032B2 (en) 2013-08-20
PT1815028E (pt) 2012-01-24
WO2006137933A3 (en) 2007-05-03
EP1815028B1 (en) 2011-10-26
JP2008518973A (ja) 2008-06-05

Similar Documents

Publication Publication Date Title
DK1815028T3 (da) Mikrobobler til affinitetsseparation
ATE515702T1 (de) Verfahren, mixturen, kits und zusammensetzungen bezüglich der analytbestimmung
WO2007100506A3 (en) Mass tags for quantitative analyses
WO2007098184A3 (en) Methods and compositions for analyte detection
EP1716257B8 (en) New primers and probes for the detection of parvovirus b19
DE60230672D1 (de) Nukleinsäureanreicherung
MX358705B (es) Agentes de union de esclerostina.
WO2006119062A3 (en) Sclerostin epitopes
WO2006105152A3 (en) Amnion-derived cell compositions, methods of making and uses thereof
WO2003022028A3 (en) Methods, reagents, kits and apparatus for protein function analysis
EA200702278A1 (ru) Антитела, специфичные в отношении tgf-бета 1
WO2008085962A3 (en) Cell culture methods for producing recombinant proteins in the presence of reduced levels of one or more contaminants
WO2005107491A3 (en) Multi-lectin affinity chromatography and uses thereof
WO2007070381A3 (en) Nucleic acid purification with a binding matrix
EA200700094A1 (ru) Способ промышленной очистки образцов клеток для получения терапевтических протеинов
WO2006052419A3 (en) Nucleic acid enzyme light-up sensor utilizing invasive dna
WO2008083493A8 (en) Stabilization of cyclic peptide structures
WO2011142781A3 (en) Pore-limit electrophoresis (ple) microchannel assays
WO2005085869A3 (en) Determination of analyte characteristics based upon binding properties
WO2006087163A3 (en) Novel in vitro methods for studying receptors recognizing volatile compounds
ATE497779T1 (de) Enzyme zur reduzierung von immunologischem stress
ATE532875T1 (de) Reinigungsverfahren und ihre verwendungen
WO2005044849A3 (en) Lp mammalian proteins; related reagents
WO2005014847A3 (en) Reagents, methods and kits for detecting feed enzymes
AU2003259750A1 (en) Methods and compositions for targeting secretory lysosomes